Clinical efficacy of sitafloxacin for refractory non-tuberculous mycobacterial lung disease: A single-center retrospective study

Y. Nakamura (Matsusaka, Japan), O. Hataji (Matsusaka, Japan), K. Furuhashi (Matsusaka, Japan), Y. Suzuki (Matsusaka, Japan), T. Sakaguchi (Matsusaka, Japan), K. Ito (Matsusaka, Japan), Y. Nishii (Matsusaka, Japan), O. Taguchi (Matsusaka, Japan), G. Esteban Cesar (Tsu, Japan)

Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Session: Clinical investigations of non-TB mycobacterial infection
Session type: Thematic Poster
Number: 2930

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Nakamura (Matsusaka, Japan), O. Hataji (Matsusaka, Japan), K. Furuhashi (Matsusaka, Japan), Y. Suzuki (Matsusaka, Japan), T. Sakaguchi (Matsusaka, Japan), K. Ito (Matsusaka, Japan), Y. Nishii (Matsusaka, Japan), O. Taguchi (Matsusaka, Japan), G. Esteban Cesar (Tsu, Japan). Clinical efficacy of sitafloxacin for refractory non-tuberculous mycobacterial lung disease: A single-center retrospective study. 2930

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: